Skip to main content
Equibles

MetLife Investment Management, LLC

Position in PBYI — Puma Biotechnology, Inc.

CIK 1529735 Whippany, NJ
Back to PBYI Full portfolio

Position in PBYI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$201,720
+$100,490 QoQ
Shares Held
24,873
+57.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 160 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PBYI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. PBYI ranks #192 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in PBYI

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $201,720 24,873
2026-03-31 $101,230 15,842
2025-12-31 $145,251 24,412
2025-09-30 $77,233 14,545
2025-06-30 $93,151 27,158
2025-03-31 $80,278 27,121
2024-06-30 $35,771 10,973
2021-03-31 $23,250 2,392
2020-12-31 $141,495 13,791
2020-09-30 $139,151 13,791
2020-06-30 $143,840 13,791
2020-03-31 $116,396 13,791